Influenza News and Research

Latest Influenza News and Research

GSK receives HHS' BARDA contract to support development of Gram-negative antibiotic, GSK2251052

Anacor Pharmaceuticals announced today that its partner, GlaxoSmithKline (GSK), has been awarded a contract with the U.S. Department of Health and Human Services' (HHS) Biomedical Advanced Research and Development Authority (BARDA) to support the ongoing development of GSK2251052 (GSK '052, formerly AN3665), a novel boron-based Gram-negative systemic antibiotic discovered by Anacor.

7 Sep 2011

March of Dimes urges all pregnant women to get influenza immunization

Getting a flu shot during pregnancy protects the mom-to-be from what could be a very serious – even fatal – illness and can protect her newborn who is too young to receive his or her own immunization.

7 Sep 2011

NanoViricides selects NV-INF-1 anti-influenza drug for FDA submission

NanoViricides, Inc. announced today that it has selected a clinical candidate, now designated NV-INF-1, for FDA submission in its highly successful FluCide anti-influenza therapeutics program.

6 Sep 2011

Three cases of novel influenza A virus now linked to agricultural fair in southwestern Pennsylvania

The Pennsylvania departments of Health and Agriculture today announced three cases of a novel influenza A virus have been identified, and are now linked to an agricultural fair in southwestern Pennsylvania.

6 Sep 2011

Scientists hope to create models that can more accurately predict spread of disease

Northwestern University professor Dirk Brockmann and his group at the McCormick School of Engineering and Applied Science have investigated the outcomes of a previously ignored mechanism in modeling how humans travel.

3 Sep 2011

Researchers discover protein signals responsible for preserving anti-viral antibodies

Our immune system is capable of a remarkable feat: the ability to remember infections for years, even decades, after they have first been encountered and defeated. While the antibodies we make last only about a month, we retain the means of making them for a lifetime.

3 Sep 2011

Finland national health institute finds link between H1N1 flu vaccine and children's narcolepsy

"Finland's national health institute said on Thursday its latest research on previously found links between children's narcolepsy and GlaxoSmithKline's Pandemrix vaccine against H1N1 swine flu also involved a genetic risk factor," Reuters reports.

3 Sep 2011

New IDSA/PIDS guidelines can thwart pneumonia in children

Immunizations, including a yearly flu vaccine, are the best way to protect children from life-threatening pneumonia, according to new guidelines from the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

2 Sep 2011

Tamiflu resistant flu found in Newcastle, Australia

The influenza pandemic has gathered a lot of action, advice and coverage over the last few years. In 2009, an international H1N1 influenza pandemic led to concerns that there would be a repeat of the 1918 influenza pandemic which resulted in millions of deaths worldwide. The World Health Organization recorded over 37,000 cases of the H1N1 pandemic influenza in Australia and 193 confirmed deaths.

2 Sep 2011

SAIC awards Selecta a subcontract to develop synthetic nanoparticle vaccine for malaria

Selecta Biosciences, Inc., a biopharmaceutical company developing an entirely new class of targeted vaccines and immunotherapies, today announced that Science Applications International Corporation (SAIC) has awarded Selecta a subcontract to develop a targeted synthetic vaccine particle product for malaria.

31 Aug 2011

Symptom-based viral load testing detects HIV in MSM

Testing for HIV when flu-like symptoms develop may offer a cost-effective alternative for early detection of HIV infection in men who have sex with men (MSM), reports a study in the journal AIDS.

31 Aug 2011

Bird flu on the rise again

Avian or bird flu is showing signs of a resurgence, while a mutant strain – that cannot be prevented by vaccination - could be spreading in Asia, the United Nations has warned. This mutant strain appeared in Vietnam and China and its risk to humans cannot be predicted, veterinary officials said.

30 Aug 2011

Autism link to vaccines dispelled by a large review of studies

According to a report issued by the US Institute of Medicine (IOM), vaccines are largely safe, and do not cause autism or diabetes. This conclusion followed a review of more than 1,000 published research studies.

26 Aug 2011

IOM report: Few health problems are clearly associated with vaccines

An analysis of more than 1,000 research articles concluded that few health problems are caused by or clearly associated with vaccines.

26 Aug 2011

PLoS One publishes data from recent animal studies of NanoBio's intranasal RSV vaccine

NanoBio Corporation announced today that data from recent animal studies of its NanoStat-based intranasal respiratory syncytial virus (RSV) vaccine have been published in PLoS One, an international peer-reviewed online publication.

25 Aug 2011

Study finds children's hospitals underequipped to handle H1N1 pandemics

A new study of children's hospitals nationwide has found them underequipped to handle a major surge of patients in the event of a pandemic, and urges health care institutions and government agencies to immediately review emergency preparedness plans as flu season approaches.

24 Aug 2011

Research may help explain why live attenuated influenza vaccine elicits protection

New research from the Trudeau Institute may help to explain why live attenuated influenza vaccine (LAIV), commonly known as FluMist, elicits protection.

24 Aug 2011

MSFHR announces recipients of 2010/11 health research scholar and trainee funding competitions

The Michael Smith Foundation for Health Research (MSFHR) is pleased to announce the recipients of its 2010/11 research scholar and trainee funding competitions. Of the more than 300 applicants, MSFHR has funded 95 individuals working in diverse fields of health research.

24 Aug 2011

FDA clears IQuum's Liat influenza A/B assay, analyzer

IQuum, Inc. announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market the Liat Influenza A/B Assay and the Liat Analyzer.

23 Aug 2011

Micro-organisms hide themselves from immune defences

That micro-organisms have a great capacity to vary their surface structure is well known. It is one of the reasons why it is so difficult to develop vaccines against HIV and malaria, and why new influenza vaccines have to be produced every year. But it seems that these micro-organisms are also able to completely avoid activating a strong immune response in the person attacked.

22 Aug 2011

Influenza News and Research

Latest Influenza News and Research

GSK receives HHS' BARDA contract to support development of Gram-negative antibiotic, GSK2251052

March of Dimes urges all pregnant women to get influenza immunization

NanoViricides selects NV-INF-1 anti-influenza drug for FDA submission

Three cases of novel influenza A virus now linked to agricultural fair in southwestern Pennsylvania

Scientists hope to create models that can more accurately predict spread of disease

Researchers discover protein signals responsible for preserving anti-viral antibodies

Finland national health institute finds link between H1N1 flu vaccine and children's narcolepsy

New IDSA/PIDS guidelines can thwart pneumonia in children

Tamiflu resistant flu found in Newcastle, Australia

SAIC awards Selecta a subcontract to develop synthetic nanoparticle vaccine for malaria

Symptom-based viral load testing detects HIV in MSM

Bird flu on the rise again

Autism link to vaccines dispelled by a large review of studies

IOM report: Few health problems are clearly associated with vaccines

PLoS One publishes data from recent animal studies of NanoBio's intranasal RSV vaccine

Study finds children's hospitals underequipped to handle H1N1 pandemics

Research may help explain why live attenuated influenza vaccine elicits protection

MSFHR announces recipients of 2010/11 health research scholar and trainee funding competitions

FDA clears IQuum's Liat influenza A/B assay, analyzer

Micro-organisms hide themselves from immune defences

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Influenza News and Research

Latest Influenza News and Research

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Newsletters you may be interested in